South Korea Depression Screening Market to 2032
Overview
The South Korea Depression Screening Market is expected to reach a 160.61 USD Million by 2032 and is projected to grow at a CAGR of 11.73% from 2025 to 2032.
Revenue, 2024 (USD Million)
73.90
Forecast, 2032 (USD Million)
160.61
CAGR, 2024 - 2032
11.73%
Report Coverage
South Korea
South Korea Depression Screening Market 2018-2032 USD Million
South Korea Depression Screening Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 73.90 USD Million
- Projected Market Size (2032): 160.61 USD Million
- CAGR (2025-2032): 11.73%
Key Findings of South Korea Depression Screening Market
- The South Korea Depression Screening Market was valued at 73.90 USD Million in 2024.
- The South Korea Depression Screening Market is likely to grow at a CAGR of 11.73% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Major Depressive Disorder (MDD) in Depression Type Segment accounted for the largest share of the market with a revenue of 47.84 USD Million
- The fastest growing segment Lab Tests in Diagnosis Segment grew Fastest with a CAGR of 12.39% during the forecast period from 2024 to 2032.
South Korea Depression Screening Market Scope
South Korea Depression Screening Market Segmentation & Scope
Depression Type
- Others
- Persistent Depressive Disorder (PDD)
- Major Depressive Disorder (MDD)
Diagnosis
- Lab Tests
- Screening
End-User
- Medical Research Centers
- Others
- Specialty Clinics
- Hospital
South Korea Depression Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 73.90 USD Million |
| Market Value in 2032 | 160.61 USD Million |
| CAGR (2025-2032) | 11.73% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Depression Type,Diagnosis,End-User |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 73.90 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 73.90 USD Million in 2024.
Segments and Scope
-
South Korea Depression Screening Market to 2032, By Depression Type
- Major Depressive Disorder (MDD) is the largest segment in South Korea Depression Screening Market to 2032 with a revenue of 47.84 USD Million in the year 2024.
- Major Depressive Disorder (MDD) is the Fastest growing segment in South Korea Depression Screening Market to 2032 with a Growth rate of 12.03 % in forecast period 2025-2032.
-
South Korea Depression Screening Market to 2032, By Diagnosis
- Screening is the largest segment in South Korea Depression Screening Market to 2032 with a revenue of 47.25 USD Million in the year 2024.
- Lab Tests is the Fastest growing segment in South Korea Depression Screening Market to 2032 with a Growth rate of 11.35 % in forecast period 2025-2032.
-
South Korea Depression Screening Market to 2032, By End-User
- Hospital is the largest segment in South Korea Depression Screening Market to 2032 with a revenue of 34.70 USD Million in the year 2024.
- Hospital is the Fastest growing segment in South Korea Depression Screening Market to 2032 with a Growth rate of 12.07 % in forecast period 2025-2032.
South Korea Depression Screening Market Company Share Analysis
| Company Name |
|
||
| Koninklijke Philips N.V. | |||
| Apple Inc. | |||
| Lifetrack Medical Systems | |||
South Korea Depression Screening Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Depression Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Depression Screening Market is segmented based on Segmentation Depression Type,Diagnosis,End-User.
South Korea Depression Screening Market was valued at USD 73.90(Revenue in USD Million) in 2023.
South Korea Depression Screening Market is projected to grow at a CAGR of 11.73% during the forecast period of 2024 to 2032.
The Major Depressive Disorder (MDD) segment is expected to dominate the South Korea Depression Screening Market, holding a largest market share of 47.84 USD Million in 2024
South Korea Depression Screening Market Scope
South Korea Depression Screening Market Segmentation & Scope
Depression Type
- Others
- Persistent Depressive Disorder (PDD)
- Major Depressive Disorder (MDD)
Diagnosis
- Lab Tests
- Screening
End-User
- Medical Research Centers
- Others
- Specialty Clinics
- Hospital
Frequently Asked Questions
The South Korea Depression Screening Market is segmented based on Segmentation Depression Type,Diagnosis,End-User.
South Korea Depression Screening Market was valued at USD 73.90(Revenue in USD Million) in 2023.
South Korea Depression Screening Market is projected to grow at a CAGR of 11.73% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Depression Screening Market for final year is USD 160.61 (USD Million).
South Korea Depression Screening Market Company Profiling
Frequently Asked Questions
The South Korea Depression Screening Market is segmented based on Segmentation Depression Type,Diagnosis,End-User.
South Korea Depression Screening Market was valued at USD 73.90(Revenue in USD Million) in 2023.
South Korea Depression Screening Market is projected to grow at a CAGR of 11.73% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Depression Screening Market for final year is USD 160.61 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.